Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Stem Cell Transplant for Sickle Cell Disease and Thalassemia
NCT00408447Phase 2Active, not recruiting
- Sponsor
- Columbia University
- Start
- Sep 2004
- Primary completion
- Feb 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in sickle cell disease (SCD), beta thalassemia, sponsored by Columbia University. Started Sep 2004; status: active, not recruiting.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
sickle cell disease (SCD)beta thalassemia
Beyond the preview
Go deeper on NCT00408447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408447.